ScoreWhy is Fischer Medical Ventures Ltd ?
1
Poor Management Efficiency with a low ROE of 5.57%
- The company has been able to generate a Return on Equity (avg) of 5.57% signifying low profitability per unit of shareholders funds
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
The company has declared positive results for the last 3 consecutive quarters
- PBDIT(Q) Highest at Rs 21.57 cr.
- OPERATING PROFIT TO NET SALES(Q) Highest at 21.34%
- PBT LESS OI(Q) Highest at Rs 20.10 cr.
4
Stock is technically in a Mildly Bearish range
- The stocks MACD and Bollinger Band technical factors are also Bearish
5
With ROE of 5.6, it has a Very Expensive valuation with a 6.7 Price to Book Value
- Over the past year, while the stock has generated a return of -54.17%, its profits have fallen by -20%
6
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Commodity Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Fischer Medical for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Fischer Medical
-68.0%
-0.94
57.69%
Sensex
-11.8%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
283.50%
EBIT Growth (5y)
388.62%
EBIT to Interest (avg)
5.09
Debt to EBITDA (avg)
7.80
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
0.34
Tax Ratio
36.69%
Dividend Payout Ratio
21.64%
Pledged Shares
6.81%
Institutional Holding
6.83%
ROCE (avg)
3.22%
ROE (avg)
3.53%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
87
Industry P/E
42
Price to Book Value
5.54
EV to EBIT
53.00
EV to EBITDA
48.82
EV to Capital Employed
4.74
EV to Sales
6.03
PEG Ratio
0.04
Dividend Yield
0.16%
ROCE (Latest)
7.54%
ROE (Latest)
6.64%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
NET SALES(Latest six months)
At Rs 179.46 cr has Grown at 147.16%
PAT(9M)
At Rs 10.58 cr has Grown at 79.93%
ROCE(HY)
Highest at 9.52%
-14What is not working for the Company
INTEREST(Latest six months)
At Rs 7.20 cr has Grown at 361.54%
PAT(Q)
At Rs 3.79 cr has Fallen at -40.7% (vs previous 4Q average
PBT LESS OI(Q)
At Rs 6.35 cr has Fallen at -12.9% (vs previous 4Q average
DEBT-EQUITY RATIO(HY)
Highest at 0.28 times
Loading Valuation Snapshot...
Here's what is working for Fischer Medical
Net Sales - Latest six months
At Rs 179.46 cr has Grown at 147.16%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Fischer Medical
Interest - Latest six months
At Rs 7.20 cr has Grown at 361.54%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit After Tax (PAT) - Quarterly
At Rs 3.79 cr has Fallen at -40.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.39 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 6.35 cr has Fallen at -12.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 7.29 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Debt-Equity Ratio - Half Yearly
Highest at 0.28 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
